Abstract
BackgroundPatients with systemic autoimmune rheumatic diseases (SARD) often have a prolonged pre-clinical phase during which they are anti-nuclear antibody (ANA)+ but lack clinical symptoms. Here we sought to determine whether...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have